Lipidomic Evidence for Cannabidiol-Induced Remodeling of Cellular Lipid Composition in SH-SY5Y Cells
Cells · 2026
DOI: 10.3390/cells15181714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Oliver Walzer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neurology, Saarland University, 66421 Homburg, Germany. Hauptthemen laut MEDLINE: Cannabidiol, Lipidomics, Lipid Metabolism, Lipids. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BMBF grants Multi-Memo, Carl-Zeiss foundation, European Commission.
Abstract (Originalsprache)
Cannabidiol (CBD) is increasingly discussed in relation to neurodegenerative disorders, including Alzheimer’s disease (AD), yet its effects on cellular lipid profiles remain poorly understood. Using targeted lipidomics, we investigated whether CBD alters the lipidome of SH-SY5Y wildtype (wt) cells and whether the principal phosphatidylcholine response is also observed in cells expressing amyloid precursor protein with the Swedish mutation (APPswe). CBD induced a broad, class-specific lipid response. Total diacyl and ether-linked phosphatidylcholines increased. Within these classes, many species with lower degrees of unsaturation increased, whereas several highly polyunsaturated ether-linked phosphatidylcholines declined. Lysophosphatidylcholines were broadly reduced, total sphingomyelin abundance declined, free carnitine decreased, and most measured acylcarnitine species also declined. Together, in wt cells, these changes are consistent with a relative shift toward a less polyunsaturated lipid profile. CBD-associated changes in both phosphatidylcholine classes were also observed in stably APPswe-expressing SH-SY5Y cells. Because the affected lipid classes have been implicated in AD-related lipid dysregulation, these findings link CBD exposure to an AD-relevant lipid context and provide a rationale for investigating the functional consequences of this response in more complex neurodegeneration-relevant models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Neurology, Saarland University, 66421 Homburg, Germany.
- Faculty of Computer Sciences and Microsystems Technology Kaiserslautern, University of Applied Sciences, 66482 Zweibrücken, Germany.
- Department of Psychiatry and Psychotherapy, University Medical Center, Johannes Gutenberg University Mainz, 55122 Mainz, Germany.
- Nutrition Therapy and Counseling, Campus Rheinland, SRH University of Applied Health Sciences, 51377 Leverkusen, Germany.
- Deutsches Institut für Demenzprävention (DIDP), Saarland University, 66421 Homburg, Germany.
ORCID-Profile: Oliver Walzer, Kristina Endres, Tobias Hartmann, Marcus Otto Walter Grimm
Förderung
- BMBF grants Multi-Memo
- Carl-Zeiss foundation
- European Commission
- EU Joint Program—Neuro-degenerative Disease Research
- EURO-FINGERS
Zitieren
APA
Walzer, O., Erhardt, V. K. J., Zügner, J. S. R., Izarova, N. V., Endres, K., Grimm, H. S., Hartmann, T., & Grimm, M. O. W. (2026). Lipidomic Evidence for Cannabidiol-Induced Remodeling of Cellular Lipid Composition in SH-SY5Y Cells. Cells. https://doi.org/10.3390/cells15181714
Vancouver
Walzer O, Erhardt VKJ, Zügner JSR, Izarova NV, Endres K, Grimm HS, et al. Lipidomic Evidence for Cannabidiol-Induced Remodeling of Cellular Lipid Composition in SH-SY5Y Cells. Cells. 2026. doi:10.3390/cells15181714
BibTeX
@article{Walzer2026,
author = {Walzer, Oliver and Erhardt, Vincent Konrad Johannes and Zügner, Jill Sven René and Izarova, Natalya V and Endres, Kristina and Grimm, Heike Sabine and Hartmann, Tobias and Grimm, Marcus Otto Walter},
title = {Lipidomic Evidence for Cannabidiol-Induced Remodeling of Cellular Lipid Composition in SH-SY5Y Cells},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15181714}
}
EUVIMED